Enveric Biosciences (ENVB) Revenue (2014 - 2020)
Enveric Biosciences (ENVB) posted Revenue of $8.5 million for Q3 2020, up 2.76% sequentially from $8.3 million in Q2 2020, and down 7.28% YoY from $9.1 million in Q4 2019.
Enveric Biosciences (ENVB) Revenue (2014 - 2020) Analysis & Trends
Enveric Biosciences has reported Revenue for 7 years, with the latest figure at $8.5 million in Q3 2020.
- Quarterly Revenue fell 7.28% year-over-year to $8.5 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $35.4 million (down 13.93% YoY) and the FY2019 annual result came in at $39.9 million, down 7.17% from the prior year.
- Revenue advanced to $8.5 million in Q3 2020 per ENVB's latest filing, from $8.3 million in the prior quarter.
- Over five years, Revenue peaked at $12.5 million in Q3 2017 and troughed at $6.7 million in Q2 2016.
- A 5-year average of $10.2 million and a median of $10.6 million in 2018 frame the typical range for Revenue.
- The sharpest annual moves came in 2016 and 2020: Revenue soared 125.37% in 2016, then retreated 25.06% in 2020.
- Over 5 years, Revenue stood at $12.4 million in 2016, then fell by 7.53% to $11.5 million in 2017, then retreated by 10.23% to $10.3 million in 2018, then fell by 11.85% to $9.1 million in 2019, then declined by 6.42% to $8.5 million in 2020.
- According to Business Quant data, Revenue over the past three periods registered $8.5 million, $8.3 million, and $9.6 million for Q3 2020, Q2 2020, and Q1 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Enveric Biosciences | 5.42 Mn | -2.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 8.48 Mn |
| Jun 30, 2020 | 8.25 Mn |
| Mar 31, 2020 | 9.60 Mn |
| Dec 31, 2019 | 9.06 Mn |
| Sep 30, 2019 | 9.15 Mn |
| Jun 30, 2019 | 11.02 Mn |
| Mar 31, 2019 | 10.69 Mn |
| Dec 31, 2018 | 10.28 Mn |
| Sep 30, 2018 | 10.58 Mn |
| Jun 30, 2018 | 11.08 Mn |
| Mar 31, 2018 | 11.06 Mn |
| Dec 31, 2017 | 11.45 Mn |
| Sep 30, 2017 | 12.53 Mn |
| Jun 30, 2017 | 12.27 Mn |
| Mar 31, 2017 | 12.34 Mn |
| Dec 31, 2016 | 12.39 Mn |
| Sep 30, 2016 | 10.06 Mn |
| Jun 30, 2016 | 6.69 Mn |
| Mar 31, 2016 | 7.01 Mn |
| Dec 31, 2015 | 7.58 Mn |